###begin article-title 0
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 50 58 <span type="species:ncbi:9606">Patients</span>
Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A Gene
###end article-title 0
###begin article-title 1
Type 2 Diabetes: Hypoinsulinism, Hyperinsulinism, or Both?
###end article-title 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 594 604 590 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A/TCF1</italic>
###xml 669 674 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 193 198 <span type="species:ncbi:9606">women</span>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 719 723 <span type="species:ncbi:10090">mice</span>
Macrosomia is associated with considerable neonatal and maternal morbidity. Factors that predict macrosomia are poorly understood. The increased rate of macrosomia in the offspring of pregnant women with diabetes and in congenital hyperinsulinaemia is mediated by increased foetal insulin secretion. We assessed the in utero and neonatal role of two key regulators of pancreatic insulin secretion by studying birthweight and the incidence of neonatal hypoglycaemia in patients with heterozygous mutations in the maturity-onset diabetes of the young (MODY) genes HNF4A (encoding HNF-4alpha) and HNF1A/TCF1 (encoding HNF-1alpha), and the effect of pancreatic deletion of Hnf4a on foetal and neonatal insulin secretion in mice.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 402 403 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 485 490 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 556 557 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 698 703 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 766 771 763 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 459 466 <span type="species:ncbi:9606">infants</span>
###xml 723 727 <span type="species:ncbi:10090">Mice</span>
We examined birthweight and hypoglycaemia in 108 patients from families with diabetes due to HNF4A mutations, and 134 patients from families with HNF1A mutations. Birthweight was increased by a median of 790 g in HNF4A-mutation carriers compared to non-mutation family members (p < 0.001); 56% (30/54) of HNF4A-mutation carriers were macrosomic compared with 13% (7/54) of non-mutation family members (p < 0.001). Transient hypoglycaemia was reported in 8/54 infants with heterozygous HNF4A mutations, but was reported in none of 54 non-mutation carriers (p = 0.003). There was documented hyperinsulinaemia in three cases. Birthweight and prevalence of neonatal hypoglycaemia were not increased in HNF1A-mutation carriers. Mice with pancreatic beta-cell deletion of Hnf4a had hyperinsulinaemia in utero and hyperinsulinaemic hypoglycaemia at birth.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 178 183 178 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 283 288 283 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
HNF4A mutations are associated with a considerable increase in birthweight and macrosomia, and are a novel cause of neonatal hypoglycaemia. This study establishes a key role for HNF4A in determining foetal birthweight, and uncovers an unanticipated feature of the natural history of HNF4A-deficient diabetes, with hyperinsulinaemia at birth evolving to decreased insulin secretion and diabetes later in life.
###end p 7
###begin p 8
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
HNF4A mutations were found to be associated with a considerable increase in birthweight and macrosomia, and were a cause of neonatal hypoglycaemia.
###end p 8
###begin title 9
Editors' Summary
###end title 9
###begin title 10
Background.
###end title 10
###begin p 11
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 523 529 523 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A.</italic>
###xml 106 112 <span type="species:ncbi:9606">people</span>
###xml 245 251 <span type="species:ncbi:9606">people</span>
###xml 414 420 <span type="species:ncbi:9606">person</span>
MODY, or maturity-onset diabetes of the young, is a particular subtype of diabetes; only a few percent of people with diabetes are thought to have this subtype. The condition comes about as a result of a mutation in one of six genes. Generally, people with MODY have high glucose (sugar) levels in the blood, and the typical symptoms of diabetes, such as increased thirst and urination, typically develop when the person is below the age of 25 y. Two of the genes that are known to cause MODY are mutant forms of HNF4A and HNF1A. The proteins that are encoded by these two genes control insulin levels produced by the pancreas; when these genes are mutated, not enough insulin is produced. Without enough insulin to control blood sugar, levels rise, leading to the symptoms of diabetes. However, MODY can be managed by many of the same interventions as other types of diabetes, such as diet, exercise, drug treatments, and insulin injections.
###end p 11
###begin title 12
Why Was This Study Done?
###end title 12
###begin p 13
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 78 83 78 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 362 367 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 371 376 371 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 768 773 768 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 216 221 <span type="species:ncbi:10090">mouse</span>
Although the evidence shows that individuals who carry mutations in HNF4A and HNF1A do not produce enough insulin and therefore have higher glucose levels in their blood, there were some tantalizing suggestions from mouse experiments that this might not be the whole story. Specifically, the researchers suspected that during embryonic development, mutations in HNF4A or HNF1A might actually cause higher insulin levels. Too much insulin during development of a fetus is known to cause it to gain weight, resulting in a baby that is larger than the average size for its age. Larger babies are risky for both the baby and the mother. The researchers doing this study wanted to understand more precisely what the links were between the forms of MODY caused by HNF4A and HNF1A mutations, and birth-weight and blood-sugar levels.
###end p 13
###begin title 14
What Did the Researchers Do and Find?
###end title 14
###begin p 15
###xml 114 120 114 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A.</italic>
###xml 395 401 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A.</italic>
###xml 486 491 486 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 669 674 669 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 732 737 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 979 985 979 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A.</italic>
###xml 196 202 <span type="species:ncbi:9606">people</span>
###xml 254 260 <span type="species:ncbi:9606">people</span>
###xml 649 655 <span type="species:ncbi:9606">people</span>
###xml 699 705 <span type="species:ncbi:9606">people</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 959 964 <span type="species:ncbi:10090">mouse</span>
###xml 1034 1039 <span type="species:ncbi:10090">mouse</span>
In this study, the researchers examined 15 families in which some family members had MODY caused by a mutation in HNF4A. They compared the birthweight for family members carrying the mutation (54 people) against the birthweight for those who did not (54 people). A similar comparison was done for 38 families in which some members had a different form of MODY, this time caused by a mutation in HNF1A. The results showed that the birthweight of family members who carried a mutation in HNF4A was, on average, 790 g higher than the birthweight of family members who didn't carry the mutation. Low blood-sugar levels at birth were also more common in people carrying the HNF4A mutation as compared to people who did not. However, the HNF1A mutation did not seem to be associated with greater birthweight or low blood-sugar levels at birth. Finally, in order to understand these findings further, the researchers created embryonic mice carrying mutations in the mouse equivalent of HNF4A. These embryos produced more insulin than normal mouse embryos and, after birth, were more likely to have low blood-sugar levels.
###end p 15
###begin title 16
What Do These Findings Mean?
###end title 16
###begin p 17
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A,</italic>
###xml 80 86 80 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A,</italic>
###xml 352 358 352 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A,</italic>
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 830 835 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1011 1016 1011 1016 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 315 320 <span type="species:ncbi:9606">human</span>
###xml 815 820 <span type="species:ncbi:9606">women</span>
These findings show that there is a link between mutations in HNF4A, but not in HNF1A, and increased birthweight. The increase found in this study is quite substantial (a median weight of 4,660 g in the affected babies; a birthweight of more than 4,000 g is generally considered large). The results suggest that in human embryos with a mutated form of HNF4A, too much insulin is produced during development, causing faster growth and a higher chance of the baby being born with low blood-sugar levels. This is an unexpected finding, because later in life the HNF4A mutation causes lower insulin levels. Therefore, the biochemical pathways causing this type of MODY seem to be quite complicated, and further research will need to be done to fully understand them. Crucially, the research also suggests that pregnant women carrying HNF4A mutations should be closely followed to check their baby's growth and minimize the chance of complications. Doctors and families should also consider doing a genetic test for HNF4A if a baby has low blood-sugar levels and if there is a family history of diabetes; this would increase the chance of diagnosing MODY early.
###end p 17
###begin title 18
Additional Information.
###end title 18
###begin p 19
Please access these Web sites via the online version of this summary at  0040118.
###end p 19
###begin p 20
###xml 17 31 17 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLoS Medicine,</italic>
In a related  in PLoS Medicine, Benjamin Glaser discusses causes of type 2 diabetes mellitus in the context of this study's findings
###end p 20
###begin p 21
The US  has pages of information on different types of diabetes
###end p 21
###begin p 22
Wikipedia has an entry on  (MODY) (note that Wikipedia is an internet encyclopedia that anyone can edit)
###end p 22
###begin p 23
###xml 64 72 <span type="species:ncbi:9606">patients</span>
, Peninsula Medical School, Exeter, UK provides information for patients and doctors on genetic types of diabetes; the website is maintained by the research group carrying out this study
###end p 23
###begin p 24
Information from the Centers for Disease Control and Prevention on 
###end p 24
###begin title 25
Introduction
###end title 25
###begin p 26
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b001">1</xref>
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b002">2</xref>
###xml 682 683 682 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b003">3</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b010">10</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b011">11</xref>
###xml 796 798 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b012">12</xref>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b013">13</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b014">14</xref>
###xml 146 152 <span type="species:ncbi:9606">humans</span>
###xml 339 344 <span type="species:ncbi:9606">women</span>
Macrosomia is associated with considerable foetal and maternal morbidity [1]. Factors that predict macrosomia are still poorly understood [2]. In humans, foetal insulin secretion is one of the key determinants of foetal growth, acting mainly in the third trimester when the weight of the foetus increases greatly. This is seen in pregnant women with diabetes when foetal sensing of maternal hyperglycemia drives insulin secretion, insulin-mediated growth, and subsequent macrosomia. In addition to such environmental factors, mutations in the genes involved in insulin secretion are also known to affect birthweight. Mutations that cause hyperinsulinaemic hypoglycaemia of infancy [3-10] are associated with increased birthweight. Conversely, genes in which mutations cause neonatal diabetes [11,12] and some forms of maturity-onset diabetes of the young (MODY) [13,14] are associated with decreased birthweight.
###end p 26
###begin p 27
###xml 75 80 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 137 143 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A,</italic>
###xml 163 167 155 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TCF1</italic>
###xml 236 241 228 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 246 251 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 356 358 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b015">15</xref>
###xml 359 361 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b016">16</xref>
###xml 416 418 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b017">17</xref>
###xml 419 421 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b018">18</xref>
###xml 441 446 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 451 456 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 629 631 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b018">18</xref>
###xml 650 655 639 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 724 726 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b019">19</xref>
###xml 727 729 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b020">20</xref>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
The transcription factors hepatocyte nuclear factor-4alpha (encoded by the HNF4A gene), and hepatocyte nuclear factor-1alpha (encoded by HNF1A, approved gene name TCF1) play a key role in the regulation of pancreatic insulin secretion. HNF4A and HNF1A mutations cause monogenic diabetes (MODY 1 and MODY3, respectively) due to decreased insulin secretion [15,16] and are key parts of an important beta-cell network [17,18]. In the pancreas, HNF1A and HNF4A form part of a common transcriptional network, which has been proposed as an explanation of the shared pancreatic phenotype seen in patients with mutations in these genes [18]. Variants in the HNF4A pancreatic promoter have also been associated with Type 2 diabetes [19,20].
###end p 27
###begin p 28
###xml 101 106 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 123 125 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b021">21</xref>
###xml 211 216 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 393 398 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 579 585 576 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A.</italic>
###xml 732 737 729 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 497 505 <span type="species:ncbi:9606">patients</span>
###xml 704 708 <span type="species:ncbi:10090">mice</span>
A recent study reported mildly reduced blood glucose and increased insulin levels in adult beta-cell Hnf4a-deficient mice [21]. As a result of this animal study, we hypothesized that mutations in the human gene HNF4A might increase foetal insulin secretion and birthweight, and cause neonatal hyperinsulinaemia and hypoglycaemia. We therefore studied birthweight and reported hypoglycaemia in HNF4A-mutation carriers and unaffected family members. As a comparison, we also studied the families of patients with mutations in the closely associated pancreatic transcription factor HNF1A. To investigate the mechanism of neonatal hypoglycaemia and increased birthweight, we also studied foetal and neonatal mice lacking both copies of Hnf4a in the pancreas.
###end p 28
###begin title 29
Methods
###end title 29
###begin title 30
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
Birthweight and Reported Hypoglycaemia in Hnf4a-Mutation Carriers
###end title 30
###begin p 31
###xml 110 115 110 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 275 281 275 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A,</italic>
###xml 502 507 502 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b022">22</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b023">23</xref>
One hundred and eight members (54 mutation carriers) of 15 families who had been found to have MODY due to an HNF4A mutation, were contacted. This group included 13 families where the mutation had previously been identified as well as two families, found after screening for HNF4A, where there was both neonatal hypoglycaemia and diabetes in a family member (see below). Where mutation status of an individual within a family had not previously been determined, DNA was extracted from a buccal sample. HNF4A was amplified and sequenced as previously described [22]. Birthweight and gestational age were primarily obtained by maternal recall. Birth centiles and weight were corrected to 40 wk of gestation and for male sex, according to UK 1990 reference curves [23].
###end p 31
###begin p 32
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 376 381 376 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
In assessment of neonatal hypoglycaemia, we report here on three patients from two families described above in whom HNF4A mutations had been identified due to coexistent familial diabetes and neonatal hypoglycaemia. In addition, we contacted 101 unselected members (48 mutation carriers) of the 13 families described above who had been found previously to have MODY due to an HNF4A mutation. In babies born to mothers with diabetes during pregnancy, hypoglycaemia that did not require intravenous glucose and lasted for less than 24 h was not considered exceptional. Any other reported incidence of hypoglycaemia at birth was followed up by case-note review. An episode of hypoglycaemia was established only if venous plasma glucose of less than 2.5 mmol/l was documented. All investigations for hyperinsulinaemic hypoglycaemia were done by the referring clinician at the time of diagnosis using their local laboratory.
###end p 32
###begin title 33
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
HNF4A Mutations in Families with both Diabetes and Hypoglycaemia
###end title 33
###begin p 34
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 473 476 473 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 484 490 484 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
After our initial observations in families with known HNF4A mutations, we went on to sequence the HNF4A gene in the probands of five further families who had been referred to the Exeter Molecular Genetics Laboratory with hyperinsulinaemic hypoglycaemia, and who had at least one first-degree relative with diabetes. No monogenic cause had been found for the hypoglycaemia or diabetes in these families: three of the hypoglycaemic probands had been sequenced for activating GCK and/or KCNJ11 mutations and, in one family, members with diabetes had been sequenced for HNF1A mutations.
###end p 34
###begin title 35
###xml 42 47 42 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
Birthweight and Reported Hypoglycaemia in HNF1A-Mutation Carriers
###end title 35
###begin p 36
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 209 214 209 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
One hundred and thirty-four members (85 mutation carriers) from 38 families with known MODY due to an HNF1A mutation were contacted. Reported birthweight and hypoglycaemia were recorded in the same way as for HNF4A-mutation carriers.
###end p 36
###begin title 37
###xml 11 15 <span type="species:ncbi:10090">Mice</span>
Transgenic Mice
###end title 37
###begin p 38
###xml 19 24 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 41 47 35 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a-</italic>
###xml 78 83 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 83 92 77 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 122 124 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b024">24</xref>
###xml 230 232 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b025">25</xref>
###xml 340 345 334 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 477 482 468 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 514 523 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040118-sg001">Figure S1</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 206 209 <span type="species:ncbi:10116">rat</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 845 849 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 1123 1127 <span type="species:ncbi:10090">mice</span>
beta-cell-specific Hnf4a mutations (beta-Hnf4a-KO) were generated by crossing Hnf4aLoxP/LoxP mice (Jackson Laboratory, ) [24] with InsPr-Cre mice, a transgenic line expressing Cre recombinase driven by the rat insulin 2 promoter [25]. Both lines were bred on a C57BL/6J genetic background. An almost complete efficiency of recombination of Hnf4a LoxP alleles in beta-cells was verified by: (1) real-time PCR quantitation in RNA from isolated islets showing an 80% reduction of Hnf4a mRNA relative to control mice (Figure S1); (2) absent Hnf-4alpha staining in >90% beta-cells on immunofluroescence analysis (unpublished data); and (3) recombination of a Rosa26LoxP-Stop-LoxP-Lacz allele in >90% of beta-cells when crossed with InsPr-Cre (unpublished data). Blood insulin and glucose were obtained after decapitation of timed embryos or neonatal mice (15-20 mice per genotype and stage). Glucose was measured with a glucose meter (Accu-Chek, Roche []). Plasma insulin levels were determined by ELISA (Mercodia, ). Genotyping was performed by PCR analysis using genomic DNA isolated from the tail tips of embryos and newborn mice.
###end p 38
###begin title 39
RNA Analysis
###end title 39
###begin p 40
###xml 37 43 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4a-</italic>
###xml 63 68 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 68 77 65 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LoxP/LoxP</sup>
###xml 309 311 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b026">26</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Isolated islets from 6-8-wk-old beta-HNF4a-KO mice and control Hnf4aLoxP/LoxP littermates were used for RNA extraction with Trizol reagent (Invitrogen, ). RNA integrity was verified with the 2100 Bioanalyzer (Agilent Technologies, ) prior to reverse transcription and real-time PCR quantitation as described [26]. Oligonucleotide sequences are available upon request.
###end p 40
###begin title 41
Statistical Analysis
###end title 41
###begin p 42
###xml 597 598 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 483 488 <span type="species:ncbi:10090">mouse</span>
Owing to the non-normal distribution of birthweight data, non-parametric analysis was used. Median centiles and birthweights were compared using the Mann-Whitney U-test. For the discordant sibling analysis, the median birthweight corrected for sex and gestation for all mutation carriers and non-mutation carriers within a sibship were compared using the Wilcoxon signed rank test. Hypoglycaemia and macrosomia categorical data were compared using Fisher's Exact test. Data from the mouse studies are presented as mean +/- standard error of the mean, and were compared by the two-tailed Student's t-test.
###end p 42
###begin title 43
Ethical Approval
###end title 43
###begin p 44
###xml 176 184 <span type="species:ncbi:9606">patients</span>
This study was approved by the North and East Devon Regional Ethics Committee, UK and the Animal Ethics Committee of the University of Barcelona School of Medicine, Spain. All patients or carers gave informed consent.
###end p 44
###begin title 45
Results
###end title 45
###begin title 46
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
Birthweight in HNF4A-Mutation Carriers
###end title 46
###begin p 47
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 104 111 104 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040118-t001">Table 1</xref>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 368 369 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 379 387 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g001">Figure 1</xref>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 493 501 493 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g001">Figure 1</xref>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 535 543 535 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g001">Figure 1</xref>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 649 654 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 788 789 788 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1149 1154 1149 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1319 1320 1319 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1330 1338 1330 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g001">Figure 1</xref>
The characteristics of all the HNF4A-mutation carriers and their unaffected family members are shown in Table 1. The median birthweight of the HNF4A-mutation carriers was the 96th centile (interquartile range 75-100) compared with the 58th centile (interquartile range 33-76) in unaffected family members, giving a difference in corrected median birthweight of 790 g, p < 0.001 (Figure 1A). A difference in birthweight was seen both when the mutation was inherited from the father, p < 0.001 (Figure 1B) or from the mother, p < 0.001 (Figure 1C). There was no effect of offspring genotype on gestational age at delivery (p = 0.29). The influence of HNF4A genotype on birthweight remained significant if the individuals from the two families referred with hyperinsulinaemia were excluded (p < 0.001). Nineteen mothers who were mutation carriers and one mother who was not a mutation carrier had diabetes during pregnancy; 11 of the 20 offspring from these pregnancies were mutation carriers. Finally, to allow for any impact of maternal hyperglycaemia, corrected median birthweight was compared in 18 sibling pairs discordant for the presence of the HNF4A mutation. The median birthweight of the mutation-carrying siblings was 4,660 g compared with a median birthweight of the non-mutation-carrying siblings of 3,640 g, p = 0.001 (Figure 1D).
###end p 47
###begin p 48
###xml 81 86 81 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 147 148 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 203 208 203 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 263 268 263 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b027">27</xref>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 950 955 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
Macrosomia, defined as a birthweight of more than 4,000 g, was present in 56% of HNF4A-mutation carriers but in only 13% of non-mutation carriers (p < 0.001). The prevalence of macrosomia was 64% if the HNF4A mutation was inherited from the mother and 46% if the HNF4A mutation was inherited from the father. In contrast in an unaffected foetus, the equivalent rates were 25% with an affected mother (p = 0.07), and 6% with an affected father (p = 0.003). Macrosomia is associated with increased foetal and maternal morbidity, and this was seen in some of the patients. The deliveries of the two siblings from family 1,023 were both complicated by severe shoulder dystocia, with 1,023-1 developing an Erb's palsy. The prevalence of extreme macrosomia, defined as a birthweight of >5,000 g, which is associated with increased neonatal mortality [27], was 15% (four neonates) in HNF4A-mutation carriers with an affected mother and 7% (two neonates) in HNF4A-mutation carriers with an affected father. No non-mutation carriers had extreme macrosomia.
###end p 48
###begin title 49
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
Neonatal Hyperinsulinaemic Hypoglycaemia in HNF4A-Mutation Carriers
###end title 49
###begin p 50
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 350 358 350 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g002">Figure 2</xref>
###xml 360 367 360 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040118-t002">Table 2</xref>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 547 554 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040118-t002">Table 2</xref>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 835 836 835 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 700 708 <span type="species:ncbi:9606">patients</span>
Transient neonatal hypoglycaemia is a feature of some HNF4A-mutation carriers. Two out of five families referred to Exeter, with hypoglycaemia and a first-degree family member with diabetes, were shown to have novel HNF4A mutations (M364R, IVS4nt-2A>G). Three out of the six mutation carriers in these families had documented neonatal hypoglycaemia (Figure 2; Table 2). In addition, five out of 48 HNF4A-mutation carriers in families previously identified with MODY had hypoglycaemia at or soon after birth lasting > 24 h and requiring treatment (Table 2). So, overall, eight out of 54 mutation carriers had neonatal hypoglycaemia compared to none of the 54 non-mutation carriers (p = 0.003). If the patients from the two additional families are excluded, there is still a significant excess of hypoglycaemia in the mutation carriers (p = 0.02).
###end p 50
###begin p 51
###xml 103 108 103 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 132 139 132 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040118-t002">Table 2</xref>
###xml 158 166 158 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g002">Figure 2</xref>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 894 901 894 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040118-t002">Table 2</xref>
###xml 422 430 <span type="species:ncbi:9606">patients</span>
###xml 467 475 <span type="species:ncbi:9606">patients</span>
###xml 586 594 <span type="species:ncbi:9606">patients</span>
###xml 680 688 <span type="species:ncbi:9606">patients</span>
The clinical features of the eight cases with established hypoglycaemia during infancy associated with HNF4A mutations are shown in Table 2. Their pedigrees (Figure 2) show that hypoglycaemia was often described only in a single family member with other carriers of the same HNF4A mutation presenting with diabetes. The prevalence of hypoglycaemia was similar if the mutation was inherited from the father (four out of 27 patients) or from the mother (four out of 27 patients), suggesting that persisting neonatal hypoglycaemia is independent of maternal glycaemia in pregnancy. In six patients, the hypoglycaemia was treated with intravenous glucose and enteral feeding, but two patients (1,018-1 and 1,309) required treatment with diazoxide and chlorothiazide for 1 and 6 mo, respectively. In both cases, there was documented inappropriate hyperinsulinaemia in the presence of hypoglycaemia (Table 2).
###end p 51
###begin title 52
###xml 22 27 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 31 35 <span type="species:ncbi:10090">Mice</span>
beta-Cell Deletion of Hnf4a in Mice
###end title 52
###begin p 53
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 107 112 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 128 133 122 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 207 212 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 343 348 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 369 370 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 381 389 365 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g003">Figure 3</xref>
###xml 481 489 465 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g003">Figure 3</xref>
###xml 570 572 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b028">28</xref>
###xml 598 603 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 768 769 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 780 788 757 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g003">Figure 3</xref>
###xml 898 903 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 971 972 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1086 1091 1057 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 1154 1155 1121 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1239 1240 1202 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1265 1273 1228 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g003">Figure 3</xref>
###xml 1355 1361 1318 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj11</italic>
###xml 1381 1386 1344 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Abcc8</italic>
###xml 1404 1415 1367 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Schad, Gck,</italic>
###xml 1420 1426 1383 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Glud1,</italic>
###xml 1444 1449 1407 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 1468 1477 1431 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pmed-0040118-sg001">Figure S1</xref>
###xml 1521 1526 1484 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 1689 1694 1652 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 562 568 <span type="species:ncbi:9606">humans</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1309 1314 <span type="species:ncbi:9606">human</span>
To directly test whether Hnf4a deficiency affects insulin secretion in utero, mice with beta-cell-specific Hnf4a deletion (beta-Hnf4a-KO) were examined during late gestation (E18.5-E20). Late-gestation beta-Hnf4a-KO embryos exhibited significantly elevated insulin concentrations (118.14 +/- 16.62 pmol/l versus 69.75 +/- 11.03 pmol/l in beta-Hnf4a-KO versus controls, p = 0.019) (Figure 3A). Glucose concentrations, which are regulated by the mother, were similar in both groups (Figure 3A). Birthweight, which in mice does not exhibit insulin dependence as in humans [28], did not differ in beta-Hnf4a-KO mice. During the neonatal period, blood glucose values were low relative to control littermates (1.35 +/- 0.35 mmol/l versus 2.50 +/- 0.28 mmol/l, respectively, p = 0.018) (Figure 3B). Blood glucose levels below 1.1 mmol/l were observed at least seven times more frequently in neonatal beta-Hnf4a-KO neonatal mice than in controls (8/15 versus 2/28, respectively, p < 0.001). This hypoglycaemia was due to increased insulin secretion, as the insulin/glucose ratio values in beta-Hnf4a-KO versus control mice were 29.8 +/- 12.0 versus 5.6 +/- 1.5 (p = 0.01), while insulin values were 23.9 +/- 6.9 pmol/l versus 11.1 +/- 3.3 pmol/l (p = 0.053), respectively (Figure 3B). The expression of genes causing human hyperinsulinaemic hypoglycaemia, namely Kcnj11 (encoding Kir6.2), Abcc8 (encoding Sur1), Schad, Gck, and Glud1, was unaltered in Hnf4a-deficient islets (Figure S1). In summary, these findings indicate that Hnf4a deficiency causes hyperinsulinism during foetal and neonatal life, supporting the suggestion that this is the underlying cause of macrosomia and hypoglycaemia in HNF4A-mutation carriers.
###end p 53
###begin title 54
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
Birthweight and Hypoglycaemia in HNF1A-Mutation Carriers
###end title 54
###begin p 55
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 100 107 100 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pmed-0040118-t001">Table 1</xref>
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A,</italic>
###xml 136 141 136 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 192 200 192 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g004">Figure 4</xref>
###xml 238 239 238 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pmed-0040118-g004">Figure 4</xref>
###xml 336 337 336 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 356 361 356 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 607 612 607 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 698 699 698 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The characteristics of the HNF1A-mutation carriers and their unaffected family members are shown in Table 1. Unlike HNF4A, mutations in HNF1A are not associated with an increased birthweight (Figure 4A), with a median difference of 10 g (p = 0.86) and a mean difference in the analysis of 24 discordant sibling-pairs (Figure 4B) of 3g (p = 0.91). Only one HNF1A-mutation carrier had neonatal hypoglycaemia requiring intravenous glucose and persisting for longer than 24 h; however, his mother had diabetes during pregnancy, and he required less than 48 h of this treatment. Hypoglycaemia was more common in HNF4A-mutation carriers (eight out of 54) than in HNF1A-mutation carriers (one out of 77), p = 0.004.
###end p 55
###begin title 56
Discussion
###end title 56
###begin p 57
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b015">15</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b022">22</xref>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 577 582 574 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 500 507 <span type="species:ncbi:9606">infants</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
We have shown that increased birthweight and macrosomia are common features of patients with HNF4A mutations and, in addition, that some individuals with HNF4A have neonatal hypoglycaemia. Although in young adults the same genetic defect results in diabetes due to reduced insulin secretion [15,22], we have shown that the mechanism for the phenotype in newborns is likely to be increased insulin secretion in utero and in the neonatal period. This is supported by hyperinsulinaemia in some affected infants with HNF4A mutations, and studies in mice with beta-cell deletion of Hnf4a clearly show hyperinsulinaemia in utero and hyperinsulinaemic hypoglycaemia in the early neonatal period.
###end p 57
###begin p 58
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 337 345 <span type="species:ncbi:9606">children</span>
HNF4A-mutation carriers are, on average, 790 g heavier than their family members who do not carry the mutation, and 56% are born with macrosomia (>4,000 g). The increase in birthweight is similar to that seen in the offspring of patients with maternal diabetes which is the commonest recognized cause of macrosomia. Forty-six percent of children with an HNF4A mutation born to affected fathers had macrosomia. This is a clear example that macrosomia may result from foetal genetics as well as from the maternal intra-uterine environment. Consideration of this should be taken into account when determining macrosomia risk, and we recommend that, in addition to maternal diabetes, a history of young-onset non-insulin-requiring paternal diabetes should prompt assessment of foetal size.
###end p 58
###begin p 59
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 513 518 513 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 892 897 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 951 956 951 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 1096 1101 1096 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
###xml 196 204 <span type="species:ncbi:9606">patients</span>
###xml 352 360 <span type="species:ncbi:9606">patients</span>
###xml 1140 1145 <span type="species:ncbi:9606">child</span>
We have described eight patients with HNF4A mutations who had one or more episodes of hypoglycaemia in the neonatal period; there was hyperinsulinaemia in all three patients who were tested. Five patients required treatment with intravenous glucose only, with resolution within 1 mo; this finding was consistent with a transient hyperinsulinaemia. Two patients had more persistent hypoglycaemia which responded well to treatment with diazoxide and chlorothiazide and subsequently resolved. Therefore, the loss of HNF4A function causes a relatively mild form of hyperinsulinaemic hypoglycaemia that is transient and diazoxide-responsive. Transient hypoglycaemia is often not investigated and as a result is understudied. We propose that neonates presenting with hypoglycaemia who have a father with diabetes, or a mother with young-onset non-insulin-requiring diabetes, should be screened for HNF4A mutations. However, three out of the five unselected HNF4A-mutation carriers with neonatal hypoglycaemia presented before their respective parent developed diabetes. Therefore, we also suggest that HNF4A mutations should be considered in any child with persistent hypoglycaemia (>24 h).
###end p 59
###begin p 60
###xml 732 737 732 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 884 889 884 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 570 578 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
###xml 999 1007 <span type="species:ncbi:9606">patients</span>
We encountered two problems resulting from the retrospective nature of this study. Firstly, hospital records were not readily available so birthweight and gestational age were ascertained by parental recall in the majority of cases. However, all this data collection was done blind to genotype and therefore any error should apply to both offspring groups. Secondly, the hypoglycaemia was often not well investigated at the time of presentation, presumably because of its transient nature. Hence, hyperinsulinaemia at birth was looked for only in three out of the eight patients presenting with hypoglycaemia, and other causes of hyperinsulinaemia were not excluded. It also means that we are uncertain whether the 46 patients with HNF4A mutations in whom hypoglycaemia was not described had undetected hypoglycaemia or were not hypoglycaemic. A prospective study of neonates born to HNF4A-mutation carriers is required for a complete assessment of the hyperinsulinaemic hypoglycaemia seen in these patients.
###end p 60
###begin p 61
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 472 477 472 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 230 236 <span type="species:ncbi:9606">humans</span>
###xml 284 290 <span type="species:ncbi:9606">humans</span>
###xml 359 367 <span type="species:ncbi:9606">patients</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
The increased birthweight and risk of macrosomia in HNF4A-mutation carriers is likely to be secondary to foetal hyperinsulinaemia. Although no measures of foetal insulin or cord insulin were available to confirm this mechanism in humans, two lines of evidence support it. Firstly, in humans, we have documented hyperinsulinaemia soon after birth in the three patients in whom it was tested, and hypoglycaemia in eight. Secondly, we have shown that mice lacking pancreatic Hnf4a have increased insulin concentrations in utero, and hyperinsulinaemic hypoglycaemia as newborns.
###end p 61
###begin p 62
###xml 56 62 56 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A-</italic>
###xml 185 187 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b015">15</xref>
###xml 188 190 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b022">22</xref>
###xml 347 349 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b029">29</xref>
###xml 350 352 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b030">30</xref>
###xml 424 427 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GCK</italic>
###xml 429 431 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b013">13</xref>
###xml 434 438 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPF1</italic>
###xml 440 442 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b031">31</xref>
###xml 445 450 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1B</italic>
###xml 452 454 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b014">14</xref>
###xml 471 477 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KCNJ11</italic>
###xml 479 481 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b032">32</xref>
###xml 482 484 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b033">33</xref>
###xml 490 495 481 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC8</italic>
###xml 507 509 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b012">12</xref>
###xml 510 512 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b034">34</xref>
###xml 677 682 668 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 971 974 962 965 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 1099 1100 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b008">8</xref>
###xml 1101 1103 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b035">35</xref>
###xml 1104 1106 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b036">36</xref>
###xml 1267 1270 1258 1261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 1281 1283 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b037">37</xref>
###xml 884 892 <span type="species:ncbi:9606">patients</span>
###xml 1164 1172 <span type="species:ncbi:9606">patients</span>
###xml 1496 1504 <span type="species:ncbi:9606">patients</span>
The increased birthweight and neonatal hypoglycaemia in HNF4A-mutation carriers seems paradoxical for a gene that is associated with a beta-cell-deficient form of young-onset diabetes [15,22], particularly as the decreased beta-cell function has been explained by decreased expression of pancreatic beta-cell genes involved in glucose metabolism [29,30]. It is in contrast to other monogenic causes of diabetes-for example, GCK [13], IPF1 [31], HNF1B [14], or activating KCNJ11 [32,33] and ABCC8 mutations [12,34] where birthweight is reduced. In these cases, the low insulin secretion that causes diabetes later is associated with decreased insulin-mediated foetal growth. In HNF4A-mutation carriers, in contrast, there would need to be a switch from increased insulin secretion in utero and neonatal life to decreased insulin secretion in later life. The closest example of this is patients with hyperinsulinaemia of infancy due to recessive and dominant mutations in KATP channel subunits, who have a high rate of diabetes at long-term follow-up even when they do not receive pancreatic surgery [8,35,36]. It has been postulated that diabetes in SUR1-deficient patients reflects increased apoptosis, in addition to abnormal regulation of secretion due to lack of KATP channels [37]. Compared to SUR1 deficiency, HNF-4alpha deficiency results in less severe hyperinsulinism, yet gives rise to a more highly penetrant and severe diabetic phenotype. It is interesting, however, that of the eight patients who developed established hypoglycaemia at birth, five developed diabetes by the age of 14 y (mean age 12.4 y), suggesting a possible earlier progression to diabetes in this group.
###end p 62
###begin p 63
###xml 54 59 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 104 106 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b021">21</xref>
###xml 107 109 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b038">38</xref>
###xml 222 227 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 290 296 284 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj11</italic>
###xml 311 314 305 308 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 339 341 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b021">21</xref>
###xml 439 445 433 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj11</italic>
###xml 458 460 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b038">38</xref>
###xml 629 634 623 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 726 731 720 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 925 927 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b021">21</xref>
###xml 988 994 982 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj11</italic>
###xml 1157 1162 1151 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 1193 1196 1187 1190 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATP</sub>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 710 715 <span type="species:ncbi:9606">human</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
Two recent studies surprisingly showed that beta-cell Hnf4a deficiency does not cause diabetes in mice [21,38]. One study paradoxically reported mildly reduced blood glucose and increased insulin levels in adult beta-cell Hnf4a-deficient mice, and ascribed this to diminished expression of Kcnj11 encoding the KATP channel subunit Kir6.2 [21]. Another study failed to confirm abnormal blood glucose and insulin levels, and reported normal Kcnj11 expression [38]. This discrepancy, together with the unexpected failure to develop hypoinsulinaemic diabetes, led us to question whether hyperinsulinaemia was an important feature of Hnf4a deficiency. In the current study, we have shown that, in parallel with the human findings, Hnf4a-deficient mice exhibit hyperinsulinaemia in the foetal and neonatal stage, as well as overt neonatal hypoglycaemia as opposed to only mildly reduced glucose at later ages as recently reported [21]. Importantly, our studies showed no abnormal expression of Kcnj11. While discrepancies in phenotype might be explained by small differences in genetic background, the current data suggest that the hyperinsulinaemic phenotype in Hnf4a deficiency is not related to KATP channel expression.
###end p 63
###begin p 64
###xml 360 365 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 641 642 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b008">8</xref>
###xml 643 645 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b035">35</xref>
###xml 646 648 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b036">36</xref>
###xml 699 705 679 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a-</italic>
###xml 592 600 <span type="species:ncbi:9606">patients</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
Further studies will need to address how Hnf-4alpha-dependent transcription in beta-cells is linked to the dual phenotype reported here. Large-scale profiling shows that Hnf-4alpha-deficient beta-cells exhibit abnormal expression of more than 10% of all islet genes (unpublished observations), many of which need to be examined as plausible candidates for the HNF4A-deficient hypersecretory phenotype. It is tempting to hypothesize that the initial defect that causes beta-cell hypersecretion might eventually lead to beta-cell exhaustion and diabetes, in analogy to what is observed in some patients with SUR1 mutations as described above [8,35,36]. However, the broad transcriptional phenotype of Hnf4a-deficient mice offers an alternative potential explanation, whereby one HNF-4alpha-dependent gene-expression defect causes hypersecretion early in life, while a separate gene-expression defect is responsible for the development of severe beta-cell failure several years after birth.
###end p 64
###begin p 65
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A-</italic>
###xml 302 307 302 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 465 467 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b018">18</xref>
###xml 468 470 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b022">22</xref>
###xml 471 473 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b039">39</xref>
###xml 474 476 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pmed-0040118-b040">40</xref>
###xml 667 673 <span type="species:ncbi:9606">humans</span>
The birthweight and incidence of hypoglycaemia in heterozygous HNF1A-mutation carriers were not different from their unaffected family members. This finding suggests that foetal insulin secretion is not increased in HNF1A-mutation carriers. Previous data had supported a common phenotype of HNF1A- and HNF4A-mutation carriers, due to a regulatory transcription factor circuit in the beta-cell with positive feedback on expression between HNF-1alpha and HNF-4alpha [18,22,39,40]. Our findings suggest that, at least in foetal life, there are clearly independent functions of these two transcription factors in the foetal beta-cell. Our data therefore suggest that, in humans, the proposed transcription-factor network is not critically required in foetal development and early post-natal life.
###end p 65
###begin title 66
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 65 73 <span type="species:ncbi:9606">Patients</span>
Box 1. Practical Clinical Points for Diagnosis and Management of Patients with HNF4A Mutations
###end title 66
###begin title 67
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
Management of pregnancy in families known to have diabetes due to HNF4A mutations
###end title 67
###begin p 68
Serial antenatal scans should be performed in any pregnancy in which the father or mother is a mutation carrier and early induction of labour is considered. This is true when the mother does not have diabetes, but particularly applies when the mother has diabetes or impaired glucose tolerance in pregnancy.
###end p 68
###begin p 69
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
All offspring of pregnancies where the father or mother is an HNF4A-mutation carrier should be tested for neonatal hypoglycaemia at birth and also 24 h after birth.
###end p 69
###begin title 70
Diagnosing MODY
###end title 70
###begin p 71
In families where there is autosomal dominant inheritance of young-onset diabetes with features consistent with a diagnosis of MODY, details of birthweight and neonatal hypoglycaemia should be specifically asked for.
###end p 71
###begin p 72
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
When macrosomia or neonatal hypoglycaemia (>24 h) is described, HNF4A should be sequenced before other genes when performing diagnostic genetic testing.
###end p 72
###begin title 73
Diagnosing and managing neonatal hypoglycaemia
###end title 73
###begin p 74
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 29 37 <span type="species:ncbi:9606">children</span>
HNF4A should be sequenced in children with neonatal hypoglycaemia, particularly if the hypoglycaemia is relatively mild or transient, or if a family member (parent or grandparent) has young-onset diabetes (<35 y).
###end p 74
###begin p 75
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A,</italic>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
In patients diagnosed as having HNF4A, resolution of symptoms should be expected in the first year, but diabetes should be expected to develop in adolescence or in early adulthood and should be screened for annually after the age of 10 y.
###end p 75
###begin title 76
Investigating macrosomia
###end title 76
###begin p 77
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
HNF4A should be sequenced as part of an investigation of unexplained macrosomia, particularly when the macrosomia is extreme, is accompanied by hypoglycaemia, or there is a family history of early-onset diabetes.
###end p 77
###begin p 78
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 597 602 590 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="boxed-text" rid="pmed-0040118-box001">Box 1</xref>
###xml 661 666 654 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 975 980 968 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
To conclude, we have shown that heterozygous HNF4A mutations are associated with a 790 g increase in birthweight, on average, and considerable risk of macrosomia. The increased birthweight is probably mediated by increased foetal insulin secretion and, in some cases, is associated with transient neonatal hyperinsulinaemia. Because HNF4A deficiency is also known to cause hypoinsulinaemic diabetes, this study shows for the first time that HNF-4alpha has dual opposing roles in the beta-cell during different periods of life. This study also has important implications for clinical practice (see Box 1). Firstly, pregnancies where a parent is known to have an HNF4A mutation should be monitored closely during pregnancy and the immediate post-natal period to minimize complications of macrosomia and neonatal hypoglycaemia. Secondly, neonates with transient or persistent hypoglycaemia and/or macrosomia and a family history of young-onset diabetes should be considered for HNF4A molecular genetic testing. Thirdly, since the foetal genotype has a considerable impact on determining birthweight, in addition to maternal factors, paternal factors (including history of diabetes) should be considered when assessing macrosomia risk.
###end p 78
###begin title 79
Supporting Information
###end title 79
###begin title 80
Translation into Spanish Prepared by the Authors
###end title 80
###begin p 81
(29 KB DOC)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin title 83
###xml 78 84 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a-</italic>
###xml 36 41 <span type="species:ncbi:9606">Human</span>
###xml 87 91 <span type="species:ncbi:10090">Mice</span>
mRNA Levels of Genes Known to Cause Human Hyperinsulinism in Control and beta-Hnf4a-KO Mice
###end title 83
###begin p 84
###xml 102 108 100 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kcnj11</italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
Data are mean +/- standard error of the mean from three different control and mutant mice, except for Kcnj11 where six control and six mutant mice were analysed.
###end p 84
###begin p 85
(28 KB PPT)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin title 87
Accession Numbers
###end title 87
###begin p 88
###xml 98 108 98 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A/TCF1</italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
The GenBank () identification numbers for the genes and gene products discussed in this paper are HNF1A/TCF1 (NM_000545.3) and HNF4A (NM_000457.3).
###end p 88
###begin p 89
###xml 42 50 <span type="species:ncbi:9606">patients</span>
###xml 309 313 <span type="species:ncbi:10090">mice</span>
The authors would like to acknowledge the patients and their referring clinicians, especially Kathryn Noyes and the genetic diabetes nurses Linda Robertson Jacqueline Jones, and Helen John, as well as Natalia del Pozo for technical assistance. Pedro L. Herrera (University of Geneva) is thanked for InsPr-Cre mice. ERP is a Clinician Scientist Fellow (National Health Service Education for Scotland), and ATH is a Wellcome Trust Research Leave Fellow.
###end p 89
###begin title 90
Abbreviation
###end title 90
###begin p 91
maturity-onset diabetes of the young
###end p 91
###begin title 92
References
###end title 92
###begin article-title 93
Fetal macrosomia
###end article-title 93
###begin article-title 94
Suspicion and treatment of the macrosomic fetus: A review
###end article-title 94
###begin article-title 95
Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy
###end article-title 95
###begin article-title 96
Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy
###end article-title 96
###begin article-title 97
Familial persistent hyperinsulinemic hypoglycemia of infancy and mutations in the sulfonylurea receptor
###end article-title 97
###begin article-title 98
Familial hyperinsulinism caused by an activating glucokinase mutation
###end article-title 98
###begin article-title 99
###xml 38 45 <span type="species:ncbi:9606">infants</span>
Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene
###end article-title 99
###begin article-title 100
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1
###end article-title 100
###begin article-title 101
Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion
###end article-title 101
###begin article-title 102
Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation
###end article-title 102
###begin article-title 103
Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel
###end article-title 103
###begin article-title 104
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes
###end article-title 104
###begin article-title 105
Mutations in the glucokinase gene of the fetus result in reduced birth weight
###end article-title 105
###begin article-title 106
###xml 148 153 <span type="species:ncbi:9606">human</span>
Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: Support for a critical role of HNF-1beta in human pancreatic development
###end article-title 106
###begin article-title 107
Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20
###end article-title 107
###begin article-title 108
Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on Chromosome 12
###end article-title 108
###begin article-title 109
Control of pancreas and liver gene expression by HNF transcription factors
###end article-title 109
###begin article-title 110
A genetic switch in pancreatic beta-cells: Implications for differentiation and haploinsufficiency
###end article-title 110
###begin article-title 111
Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes
###end article-title 111
###begin article-title 112
A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population
###end article-title 112
###begin article-title 113
The MODY1 gene HNF-4alpha regulates selected genes involved in insulin secretion
###end article-title 113
###begin article-title 114
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection
###end article-title 114
###begin article-title 115
Cross sectional stature and weight reference curves for the UK, 1990
###end article-title 115
###begin article-title 116
Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis
###end article-title 116
###begin article-title 117
Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages
###end article-title 117
###begin article-title 118
A conditional model reveals that induction of hepatocyte nuclear factor-1alpha in hnf1alpha-null mutant beta-cells can activate silenced genes postnatally, whereas overexpression is deleterious
###end article-title 118
###begin article-title 119
Macrosomic births in the United States: Determinants, outcomes, and proposed grades of risk
###end article-title 119
###begin article-title 120
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Early neonatal death in mice homozygous for a null allele of the insulin receptor gene
###end article-title 120
###begin article-title 121
The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism
###end article-title 121
###begin article-title 122
Hepatocyte nuclear factor 4alpha regulates the expression of pancreatic beta-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion
###end article-title 122
###begin article-title 123
###xml 72 77 <span type="species:ncbi:9606">human</span>
Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence
###end article-title 123
###begin article-title 124
Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes
###end article-title 124
###begin article-title 125
Activating mutations in the gene encoding Kir6.2 alter fetal and postnatal growth as well as causing neonatal diabetes
###end article-title 125
###begin article-title 126
Activating mutations in the ABCC8 gene in neonatal diabetes mellitus
###end article-title 126
###begin article-title 127
Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: High incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up
###end article-title 127
###begin article-title 128
A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1
###end article-title 128
###begin article-title 129
###xml 63 68 <span type="species:ncbi:9606">human</span>
Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy
###end article-title 129
###begin article-title 130
Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells
###end article-title 130
###begin article-title 131
A distant upstream promoter of the HNF-4alpha gene connects the transcription factors involved in maturity-onset diabetes of the young
###end article-title 131
###begin article-title 132
A transcription factor regulatory circuit in differentiated pancreatic cells
###end article-title 132
###begin title 133
Figures and Tables
###end title 133
###begin title 134
Birthweight (Adjusted for Sex and Gestational Age) according to Foetal Genotype
###end title 134
###begin p 135
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
(A) All offspring; (B) HNF4A mutation inherited from the father; (C) HNF4A mutation inherited from the mother, and (D) siblings discordant for HNF4A genotype.
###end p 135
###begin p 136
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 61 67 61 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A.</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 319 320 319 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Foetal genotype: NM, heterozygous HNF4A mutation; NN, normal HNF4A. For (A) to (C), bars represent median, the box represents interquartile range, and the whiskers represent the range, with outliers shown as circles. Comparing NM birthweight with NN birthweight by Mann-Whitney U-test: p < 0.001 for (A) all offspring; p = 0.001 for (B) father affected and for (C) mother affected. In (D), those pairs where the father has the mutation are shown as filled circles; those pairs where the mother has the mutation are shown as filled triangles. The red bars represent median birthweight.
###end p 136
###begin title 137
Pedigrees of Families with Hypoglycaemia
###end title 137
###begin p 138
###xml 328 333 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 456 463 <span type="species:ncbi:9606">patient</span>
Patients with hypoglycaemia are shaded with bold diagonal stripes; patients who had hypoglycaemia but have progressed onto diabetes are shaded with half black/half diagonal stripes; and patients with diabetes are coloured black. Probands are indicated with an arrow. Where available, below each symbol is recorded genotype (NM, HNF4A-mutation carrier; NN, unaffected), birth centile adjusted for sex and gestation, age at which diabetes developed, and the patient's treatment.
###end p 138
###begin title 139
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a</italic>
###xml 82 86 <span type="species:ncbi:10090">Mice</span>
Deletion of Hnf4a in beta-Cells Results in Hyperinsulinaemia and Hypoglycaemia in Mice
###end title 139
###begin p 140
###xml 190 196 187 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf4a-</italic>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
(A) Blood glucose, plasma insulin, and insulin/glucose ratio of E18.5-E20 embryos. (B) Blood glucose levels, plasma insulin levels, and insulin/glucose ratio of newborn mice. Data from beta-Hnf4a-KO and controls is shown in white and black bars, respectively. Values are mean +/- standard error of the mean.
###end p 140
###begin title 141
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF1A</italic>
Birthweight in HNF1A-Mutation Carriers
###end title 141
###begin p 142
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
(A) Median centile (adjusted for sex and gestation) in mutation carriers (NM) and non-mutation carriers (NN) (p = 0.86). Error bars show interquartile range. (B) Discordant sib-pair analysis. Those pairs where the father has the mutation are shown as filled circles; those pairs where the mother has the mutation are shown as filled triangles. Median birthweight: NM 3,490 g; NN 3460 g (p = 0.91).
###end p 142
###begin p 143
###xml 19 27 <span type="species:ncbi:9606">Patients</span>
Characteristics of Patients
###end p 143
###begin p 144
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF4A</italic>
###xml 21 29 <span type="species:ncbi:9606">Patients</span>
Clinical Features of Patients with HNF4A Mutations and Documented Hypoglycaemia
###end p 144
###begin p 145
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests:</bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 145
###begin p 146
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author contributions.</bold>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Author contributions. ERP, SFB, AMS, SE, JF, and ATH were involved with the study design and data analysis. The mouse studies were undertaken by SFB and JF. The human molecular genetic analysis was carried out by KS and SE. All authors were involved with interpretation of the data and preparation of the manuscript.
###end p 146
###begin p 147
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding:</bold>
Funding: This study was funded by the Wellcome Trust, National Health Service Education for Scotland, National Health Service Research and Development, Eurodia (EC 6th Framework Programme), and Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 147

